PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.\', \'Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.\', \'Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.\', \'University of Lille, CNRS, Inserm, CHU Lille, Lille, France.\', \'Centre d\'Infection et d\'Immunité de Lille, Institut Pasteur de Lille, Lille, France.\', \'Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.\', \'Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/AAC.00097-21
?:hasPublicationType
?:journal
  • Antimicrobial agents and chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33903110
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.291
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all